In this Issue:
45 and Up Study data support CRC screening
Split-course chemoradiation feasible in rectal cancer
Crizotinib active in advanced ROS1-rearranged NSCLC
Dacomitinib promising in advanced NSCLC
Gabapentin for inadequate nausea control
First-line FOLFIRI in advanced gastric adenocarcinoma
Endocrine therapy: detrimental effects on cognition
Cognitive impairment in patients with CRC
Adjuvant radiotherapy after BCS in DCIS
CTCs: prognostic significance in metastatic breast cancer
Please login below to download this issue (PDF)